Michael Barnett

19.1k total citations · 5 hit papers
246 papers, 9.5k citations indexed

About

Michael Barnett is a scholar working on Pathology and Forensic Medicine, Neurology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael Barnett has authored 246 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Pathology and Forensic Medicine, 79 papers in Neurology and 49 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael Barnett's work include Multiple Sclerosis Research Studies (147 papers), Peripheral Neuropathies and Disorders (50 papers) and Advanced Neuroimaging Techniques and Applications (29 papers). Michael Barnett is often cited by papers focused on Multiple Sclerosis Research Studies (147 papers), Peripheral Neuropathies and Disorders (50 papers) and Advanced Neuroimaging Techniques and Applications (29 papers). Michael Barnett collaborates with scholars based in Australia, United States and United Kingdom. Michael Barnett's co-authors include John W. Prineas, John Parratt, G. John Ikenberry, Martha Finnemore, Andrew Henderson, Alexander Klistorner, Stephen Reddel, Con Yiannikas, Chenyu Wang and Ian Sutton and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Michael Barnett

226 papers receiving 9.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion

2004 915 citations Michael Barnett et al. profile →
Rules for the World: International Organizations in Global Politics

2004 562 citations Michael Barnett et al. profile →
Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis

2012 470 citations Michael Barnett et al. profile →
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination

2017 390 citations Jeannette Lechner‐Scott, Steve Vucic et al. profile →
Ravulizumab in Aquaporin‐4–Positive Neuromyelitis Optica Spectrum Disorder

2023 82 citations Michael Barnett et al. profile →

Peers

Countries citing papers authored by Michael Barnett

Since Specialization

Citations

This map shows the geographic impact of Michael Barnett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Barnett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Barnett more than expected).

Fields of papers citing papers by Michael Barnett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Barnett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Barnett. The network helps show where Michael Barnett may publish in the future.

Co-authorship network of co-authors of Michael Barnett

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Barnett. A scholar is included among the top collaborators of Michael Barnett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Barnett. Michael Barnett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Longitudinal Trajectories of Digital Cognitive Biomarkers for Multiple Sclerosis 2025 ·Annals of Clinical and Translational Neurology ·Yi Chao Foong, Daniel Merlo, Melissa Gresle, Chao Zhu, Katherine Buzzard, Jeannette Lechner‐Scott, Michael Barnett, Chenyu Wang, Bruce Taylor, Tomáš Kalinčík, Trevor J. Kilpatrick, David Darby, Maria Pamela Dobay, Johan van Beek, Robert Hyde, Steve Simpson, Helmut Butzkueven, Anneke van der Walt	2
2	Neuronal somatic mutations are increased in multiple sclerosis lesions 2025 ·Nature Neuroscience ·Allan Motyer, Stacey Jackson, Bicheng Yang, Ivon Harliwong, (unknown), (unknown), (unknown), Wei Wang, Catriona McLean, Michael Barnett, Trevor J. Kilpatrick, Stephen Leslie, Justin P. Rubio	0
3	Long-term acceptability of MSReactor digital cognitive monitoring among people living with multiple sclerosis 2025 ·Multiple Sclerosis Journal ·Daniel Merlo, (unknown), Yi Chao Foong, Chao Zhu, Melissa Gresle, Tomáš Kalinčík, (unknown), Trevor J. Kilpatrick, Michael Barnett, Bruce Taylor, Katherine Buzzard, David Darby, Helmut Butzkueven, Anneke van der Walt	1
4	Low-intensity repetitive transcranial magnetic stimulation is safe and well tolerated by people living with MS – outcomes of the phase I randomised controlled trial (TAURUS) 2024 ·Multiple Sclerosis Journal - Experimental Translational and Clinical ·(unknown), Amin Zarghami, Kalina Makowiecki, Natasha Stevens, (unknown), (unknown), Chenyu Wang, Linda Ly, (unknown), Mark R. Hinder, Lewis Johnson, Jennifer Rodger, (unknown), Carlie L. Cullen, Michael Barnett, Kaylene M. Young, Bruce Taylor	3
5	3115 Longitudinal trajectories of digital cognitive biomarkers for multiple sclerosis 2024 ·SHILAP Revista de lepidopterología ·Yi Chao Foong, Daniel Merlo, Melissa Gresle, Chao Zhu, Katherine Buzzard, Jeannette Lechner‐Scott, Michael Barnett, Bruce Taylor, Tomáš Kalinčík, Trevor J. Kilpatrick, David Darby, Maria Pamela Dobay, Johan van Beek, Robert Hyde, Helmut Butzkueven, Anneke van der Walt	0
6	Longitudinal trajectories of digital upper limb biomarkers for multiple sclerosis 2024 ·European Journal of Neurology ·Yi Chao Foong, Daniel Merlo, Melissa Gresle, Chao Zhu, Katherine Buzzard, Jeannette Lechner‐Scott, Michael Barnett, Bruce Taylor, Tomáš Kalinčík, Trevor J. Kilpatrick, David Darby, Maria Pamela Dobay, Johan van Beek, Robert Hyde, Steve Simpson, Helmut Butzkueven, Anneke van der Walt	1
7	Tremor suppression following treatment with MRgFUS: skull density ratio consistency and degree of posterior dentatorubrothalamic tract lesioning predicts long-term clinical outcomes in essential tremor 2023 ·Frontiers in Neurology ·(unknown), Jerome J. Maller, Yael Barnett, Benjamin Jonker, Michael Barnett, Arkiev D’Souza, Fernando Calamante, (unknown), (unknown), Chenyu Wang, Stephen Tisch	5
8	Choroid plexus volume is enlarged in clinically isolated syndrome patients with optic neuritis 2023 ·Multiple Sclerosis Journal ·(unknown), Anneke van der Walt, Michael Barnett, Helmut Butzkueven, Scott Kolbe, John Parratt, Con Yiannikas, Alexander Klistorner	23
9	The Patient‐Determined Disease Steps scale is not interchangeable with the Expanded Disease Status Scale in mild to moderate multiple sclerosis 2023 ·European Journal of Neurology ·Yi Chao Foong, Daniel Merlo, Melissa Gresle, Chao Zhu, Katherine Buzzard, Jeannette Lechner‐Scott, Michael Barnett, Bruce Taylor, Tomáš Kalinčík, Trevor J. Kilpatrick, David Darby, Maria Pamela Dobay, Johan van Beek, Robert Hyde, Helmut Butzkueven, Anneke van der Walt	9
10	Mechanisms of central brain atrophy in multiple sclerosis 2022 ·Multiple Sclerosis Journal ·(unknown), Michael Barnett, Alexander Klistorner	13
11	The expansion and severity of chronic MS lesions follows a periventricular gradient 2022 ·Multiple Sclerosis Journal ·(unknown), Michael Barnett, Stuart L. Graham, Chenyu Wang, Alexander Klistorner	16
12	Progressive loss of hearing and balance in superficial siderosis due to occult spinal dural defects 2022 ·European Archives of Oto-Rhino-Laryngology ·G. Michael Hálmagyi, Geoffrey Parker, Liming Chen, Miriam S. Welgampola, J D Watson, Michael Barnett, Mike Todd, (unknown), Victoria Rose, Marcus A. Stoodley, Jeffrey Brennan	3
13	Targeting B Cells to Modify MS, NMOSD, and MOGAD 2021 ·Neurology Neuroimmunology & Neuroinflammation ·Jonas Graf, Jan Mareš, Michael Barnett, Orhan Aktaş, Philipp Albrecht, Scott S. Zamvil, Hans‐Peter Hartung	41
14	Nerve biopsy: Current indications and decision tools 2021 ·Muscle & Nerve ·(unknown), Judith Spies, Michael Barnett, John D. Pollard, Min‐Xia Wang, Claudia Sommer, Matthew C. Kiernan	29
15	Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study) 2021 ·JMIR Research Protocols ·Vicki E. Maltby, Rod A. Lea, Mastura Monif, Marzena J. Fabis‐Pedrini, Katherine Buzzard, Tomáš Kalinčík, Allan G. Kermode, Bruce Taylor, Suzanne Hodgkinson, Pamela McCombe, Helmut Butzkueven, Michael Barnett, Jeannette Lechner‐Scott	4
16	Blunted sweating does not alter the rise in core temperature in people with multiple sclerosis exercising in the heat 2020 ·American Journal of Physiology-Regulatory, Integrative and Comparative Physiology ·Georgia K. Chaseling, Davide Filingeri, (unknown), Michael Barnett, Steve Vucic, Scott L. Davis, Ollie Jay	10
17	Investigation of tumefactive demyelination is associated with higher economic burden and more adverse events compared with conventional multiple sclerosis 2019 ·Multiple Sclerosis and Related Disorders ·Matthew Silsby, (unknown), Judith Spies, (unknown), Joshua Barton, Heidi Beadnall, Michael Barnett, Stephen Reddel, Todd A. Hardy	7
18	Temperature sensitivity in multiple sclerosis: An overview of its impact on sensory and cognitive symptoms 2018 ·Temperature ·(unknown), Richard Bibb, Scott L. Davis, Ollie Jay, Michael Barnett, Nikos Evangelou, Davide Filingeri	60
19	Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy 2011 ·Multiple Sclerosis Journal ·Michael Barnett, (unknown), (unknown), (unknown), (unknown)	95
20	Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium. 1993 ·PubMed ·Chikao Yasunaga, Donald V. Cramer, F Chapman, (unknown), Michael Barnett, (unknown), L Makowka	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact